Related Experiment Video
Updated: Mar 29, 2026

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Early or later prophylactic INSURE in preterm infants of less than 30 weeks' gestation
Emel Okulu1, Saadet Arsan, İlke Mungan Akın
1Division of Neonatology, Department of Pediatrics, Ankara University Faculty of Medicine, Ankara, Turkey. emelokulu@gmail.com.
Insights
Early surfactant administration with nasal continuous positive airway pressure (nCPAP) did not reduce the need for mechanical ventilation (MV) in preterm infants. However, early INSURE strategy showed a trend towards shorter respiratory support duration.
Area of Science:
- Neonatal Medicine
- Respiratory Physiology
- Pediatric Critical Care
Background:
- Premature infants (<30 weeks' gestation) often require respiratory support due to immature lungs.
- Surfactant replacement therapy and nasal continuous positive airway pressure (nCPAP) are standard care.
- The optimal timing for surfactant administration (INSURE strategy) remains debated.
Purpose of the Study:
- To compare an early prophylactic INSURE strategy with early nCPAP versus a later surfactant prophylaxis (15 minutes after birth) with early nCPAP.
- To assess the impact on the need for mechanical ventilation (MV) in preterm infants.
Main Methods:
- Randomized trial of infants born at <30 weeks' gestation.
- Two groups: immediate surfactant prophylaxis vs. surfactant at 15 minutes after birth.
- All infants received poractant alpha and were managed with T-piece ventilation and transitioned to nCPAP.
Main Results:
- No significant difference in the primary outcome (need for MV within 3 days) between early and late surfactant groups (20% vs. 16.7%).
- A significantly shorter duration of total respiratory support (CPAP + MV) was observed in the early surfactant group (96h vs. 309h; P=0.038).
- Incidence of neonatal morbidities, mortality, and hospitalization duration were similar between groups.
Conclusions:
- Early prophylactic surfactant administration combined with early nCPAP did not prove superior to later administration in reducing the need for MV.
- The study identified a potential benefit of the early INSURE strategy in reducing the overall duration of respiratory support.
Abstract:
We aimed to determine whether an early prophylactic INSURE strategy combined with early nasal continuous positive airway pressure (nCPAP) treatment could decrease the subsequent need for mechanical ventilation (MV) compared to the administration of surfactant prophylaxis later, at the 15th minute after birth, combined with early nCPAP. Infants born at <30 weeks' gestation were randomized to receive surfactant prophylaxis immediately or at the 15th minute after birth. All infants received 100 mg/kg poractant alpha, were ventilated with a T-piece resuscitator and were extubated to nCPAP if they had sufficient respiratory drive. Forty infants were analyzed in each group. Ten (25%) infants in the early prophylactic INSURE group, and 13 (32.5%) infants in the later prophylactic INSURE group could not be extubated after surfactant administration in the delivery room. Among the infants who were initially extubated to nCPAP after surfactant administration, 6 in the early prophylactic INSURE group and 4 in the later prophylactic INSURE group needed intubation for MV within the first 3 days of life (20% vs. 16.7%; P=0.73). The duration of total respiratory support (CPAP plus MV) of infants who were intubated within the first 3 days of life was shorter in the early prophylactic INSURE group than in the later prophylactic INSURE group (median: 96 h vs. 309 h; P=0.038). The incidence of all neonatal morbidities and mortality and the duration of hospitalization were similar between the groups. Our study did not demonstrate superiority of early surfactant prophylaxis combined with early nCPAP to the later administration of prophylactic surfactant with early nCPAP; however, it did detect an absolute difference in the primary outcome: need for MV within the first 3 days of life.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Drug Dosing: Infants and Children
Production of Pharmaceuticals
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intrauterine Drug Delivery Systems

